Drug Type Small molecule drug |
Synonyms HMR 1794, S-1197, S-1762 + [1] |
Target |
Action antagonists |
Mechanism GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H27N5O5 |
InChIKeySSGOEPXWNBXKPQ-UUOWRZLLSA-N |
CAS Registry177563-40-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thromboembolism | Phase 1 | - | - | |
Thrombosis | Preclinical | Germany | 16 Mar 2001 |